FDA Drugs recall ·

Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only… recall

Recall number
D-0662-2026
Date
(initiated June 7, 2026)
Company / brand
Onesource Specialty Pharma Limited
Plot No.: 2-D1, Obadenahalli Industrial Area, Doddaballapura, Bengaluru, N/A, India
Category
Drugs › Class II
Classification
Class II
Status
Ongoing
Units affected
4284 vials
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, Manufactured by: OneSource Specialty, Pharma Limited, Bengaluru - 561 203, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-893-31

Why was it recalled?

Failed Impurities/Degradation Specifications

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

Lot #: 7000612A, Exp. Date 1/2028

Distribution

Nationwide within the United States

What does Class II mean?

Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.

Source: FDA (drugs), recall D-0662-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.